Browsing: Phase

Phase III trial shows up to 28.7% weight loss, but tolerability remains a key concern for Eli Lilly’s triple-agonist therapy.…

Credit: Mohammed Haneefa Nizamudeen/Getty Images Final results from a Phase I clinical study suggest that a preventive vaccine strategy for…

Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA) candidate clascoterone—both…

Early biomarker engagement and clean safety data position VNA-318 as a potential new entrant in longevity-focused neurotherapeutics. Vandria has reported…

More than two weeks after Pfizer (NYSE: PFE) and Novo Nordisk (NASDAQ Copenhagen: NOVO-B) slugged it out for Metsera (NASDAQ:…

Credit: Nicole Falkiner/ Getty Images Phase III of Singapore’s National Precision Medicine Program has launched, with aims of enrolling up…

What happened after publicationIn this paper by Attar and colleagues (BMJ 2025;391:e083382, doi:10.1136/bmj-2024-083382, published 29 October 2025), The BMJ was…

Credit: Stocktrek Images / Getty Images image of a multiple sclerosis neuron. Roche announced this week that two important Phase…

Credit: TopMicrobialStock / Adobe Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase…

PSA: It’s time to start working with your body, not against it.